1. Home
  2. IOVA vs SLNH Comparison

IOVA vs SLNH Comparison

Compare IOVA & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • SLNH
  • Stock Information
  • Founded
  • IOVA 2007
  • SLNH 1961
  • Country
  • IOVA United States
  • SLNH United States
  • Employees
  • IOVA N/A
  • SLNH N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • SLNH EDP Services
  • Sector
  • IOVA Health Care
  • SLNH Technology
  • Exchange
  • IOVA Nasdaq
  • SLNH Nasdaq
  • Market Cap
  • IOVA 1.0B
  • SLNH 6.9M
  • IPO Year
  • IOVA N/A
  • SLNH N/A
  • Fundamental
  • Price
  • IOVA $1.69
  • SLNH $0.82
  • Analyst Decision
  • IOVA Strong Buy
  • SLNH
  • Analyst Count
  • IOVA 9
  • SLNH 0
  • Target Price
  • IOVA $18.22
  • SLNH N/A
  • AVG Volume (30 Days)
  • IOVA 9.3M
  • SLNH 365.1K
  • Earning Date
  • IOVA 05-08-2025
  • SLNH 05-19-2025
  • Dividend Yield
  • IOVA N/A
  • SLNH N/A
  • EPS Growth
  • IOVA N/A
  • SLNH N/A
  • EPS
  • IOVA N/A
  • SLNH N/A
  • Revenue
  • IOVA $164,070,000.00
  • SLNH $38,021,000.00
  • Revenue This Year
  • IOVA $182.20
  • SLNH N/A
  • Revenue Next Year
  • IOVA $62.10
  • SLNH N/A
  • P/E Ratio
  • IOVA N/A
  • SLNH N/A
  • Revenue Growth
  • IOVA 13698.99
  • SLNH 80.48
  • 52 Week Low
  • IOVA $2.70
  • SLNH $0.36
  • 52 Week High
  • IOVA $13.60
  • SLNH $8.80
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 24.56
  • SLNH 53.38
  • Support Level
  • IOVA $3.02
  • SLNH $0.68
  • Resistance Level
  • IOVA $3.31
  • SLNH $0.95
  • Average True Range (ATR)
  • IOVA 0.24
  • SLNH 0.14
  • MACD
  • IOVA -0.08
  • SLNH 0.02
  • Stochastic Oscillator
  • IOVA 6.00
  • SLNH 60.38

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About SLNH Soluna Holdings Inc.

Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.

Share on Social Networks: